Search Tag: breast screening
Refining Breast Cancer Screening to Increase Effectiveness
2022 01 Aug
Cancer is a disease that, if left untreated, can progress and spread rapidly and cause death. Breast cancer has a diverse range of pathological entities and can incorporate indolent to aggressive legions. It can have varying histological patterns, clinical presentations, treatment responses and outcomes. Timely screening is essential, and intervening... Read more
Racial Disparities in Breast Cancer
2022 30 Jun
New findings published in Cancer Epidemiology Biomarkers & Prevent show significant differences in the accuracy of diagnostic mammograms across racial and ethnic groups, with variation observed in several measures of diagnostic performance. Several studies have already established that racial disparities exist in breast cancer. Multiple socioeconomic... Read more
NICE Endorses Magnetic Marker Liquid Probe for Breast Cancer Metastasis
2022 19 May
The UK National Institute for Health and Care Excellence (NICE) now endorses the use of Magtrace and Sentimag magnetic marker liquids to locate sentinel lymph nodes in women with breast cancer in a new draft guidance. Sentinel lymph nodes are the first lymph nodes that a primary tumour can drain. When the tracer is injected into a tumour, tracer... Read more
AI Catches What Radiologists Miss on Breast Screening
2022 16 May
A large German study found that AI can accurately detect and localise breast cancers on screening exams missed by radiologists, which in turn can reduce the frequency of cancers between screenings (usually 24 months). Many breast cancers are clinically detected due the onset of symptoms during the interval between breasts screenings. Often... Read more
Flatiron Data Supports Using Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer
2022 09 May
This Pfizer-sponsored study used de-identified data derived from the Flatiron Health Analytic Database in a retrospective observational study to demonstrate palbociclib (PAL) combined with an aromatase inhibitor (AI) is an effective first-line therapy for treating metastatic breast cancer. Hormone receptor-positive/human epidermal growth factor... Read more
How Good is the Evidence Informing Breast Cancer Clinical Practice Guidelines?
2022 05 May
A study published in Clinical Breast Cancer revealed that the quality of the systematic reviews that provide the evidence to inform clinical practice guidelines differed widely. The systematic reviews and meta-analyses used to inform the clinical practice guidelines for the National Comprehensive Cancer Network (U.S.) and European Society... Read more
How Do Perceptions of Radiologists and AI Systems in Breast Screening Differ?
2022 05 May
A study published in Nature Scientific Reports revealed striking differences in the way radiologists and artificial intelligence (AI) systems perceive breast cancer lesions. Given that how they recognise breast cancer differs, this New York University study demonstrates the potential value of combining both human and AI methods when making medical... Read more
ASCO’s Clinical Practice Guideline Now Supports Extended Endocrine Therapy with Breast Cancer Index™
2022 27 Apr
Hologic, Inc.announced today that the American Society of Clinical Oncology (ASCO) has published an update which expands the utility of Breast Cancer Index™ (BCI) within its Clinical Practice Guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.” Specifically, ASCO now recognizes BCI as the only genomic test... Read more
AI in Population Breast Screening Cuts Radiologist Workload by 63%
2022 25 Apr
Danish and Dutch researchers recently demonstrated that using artificial intelligence (AI) as an aid in population-based breast screening can cut radiologist workload by 63% and false positive finding by 25%. Examining the mammograms produced by population-based breast cancer screening program produces a significant workload for radiologists.... Read more
Talk. Test. Treat. STDs are Preventable, Treatable, and Mostly Curable
2022 14 Apr
Sexually Transmitted Disease (STD) Awareness Week is observed in the U.S. yearly during the second whole week of April. The U.S. Centers for Disease Control and Prevention (CDC) estimates that 20% of the U.S. (68 million) had a sexually transmitted infection (STI) in 2018. About 26 million were new infections which incurred USD $16 billion in direct... Read more